BOOST Pharma
Developer of stem cell therapy designed for the treatment of osteogenesis imperfecta. The company's treatment is based on novel mesenchymal stem cells that have high bone-forming capabilities which on...
Valuation
$0
Share Price
N/A
Total Raised
$5.1M
Last Round
N/A